Skip Navigation

European Heart Journal 1990 11(Supplement E):230-236; doi:10.1093/eurheartj/11.suppl_E.230
Copyright © 1990 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Reichl, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reichl, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1990 The European Society of Cardiology

Lipoproteins of human peripheral lymph

D. Reichl

St Bartholomew's Hospital London, U.K.

Address for correspondence: D. Reichl, Bowman Grey School of Medicine, Dept of Medicine, Section of Metabolism and Endocinology, Wiston-Salem, NC, U.S.A.

The concentration of cholesterol in peripheral lymph is roughly one tenth of that in the blood plasma of the same subject. In lymph, there is virtually no very low density lipoprotein (VLDL), probably due to low permeability of the vascular endothelium for particles of this size. More than 95% of apo B-containing lipoproteins of lymph have the density of plasma low density lipoproteins (LDL). The concentration of apo A-I and apo A-II in lymph is about 15% of that in plasma; yet about 50% of the total mass of both these main HDL apoproteins is present extravascularly. High density lipoproteins (HDL) of lymph appear square-packing, and the presence of such large HDL particles is the most conspicuous difference between lipoproteins in plasma and in the extravascular fluids. It remains to be seen whether raising plasma apo A-I concentration per se will increase the initial stages of reverse cholesterol transport and also be clinically beneficial.

Key Words: Lipoproteins • reverse cholesterol transport • lymph


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
V. Y. Fujimoto, J. P. Kane, B. Y. Ishida, M. S. Bloom, and R. W. Browne
High-density lipoprotein metabolism and the human embryo
Hum. Reprod. Update, August 28, 2009; (2009) dmp029v2.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. Mittendorfer, B. W. Patterson, and S. Klein
Effect of weight loss on VLDL-triglyceride and apoB-100 kinetics in women with abdominal obesity
Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E549 - E556.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.